Urinary microRNAs and Their Significance in Prostate Cancer Diagnosis: A 5-Year Update

被引:9
|
作者
Juracek, Jaroslav [1 ]
Madrzyk, Marie [1 ]
Stanik, Michal [2 ]
Slaby, Ondrej [1 ,3 ]
机构
[1] Masaryk Univ, Cent European Inst Technol, Brno 62500, Czech Republic
[2] Masaryk Mem Canc Inst, Dept Urol Oncol, Clin Surg Oncol, Brno 65653, Czech Republic
[3] Masaryk Univ, Dept Biol, Fac Med, Brno 62500, Czech Republic
关键词
prostate cancer; microRNA; urine; extracellular vesicles; diagnosis; EPITHELIAL-MESENCHYMAL TRANSITION; MIRNAS; IDENTIFICATION; ACTIVATION; BIOMARKERS; EXOSOMES; RECOVERY; PLASMA;
D O I
10.3390/cancers14133157
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Current diagnostics of prostate cancer often show unsatisfactory results, leading to delayed detection or overtreatment. Urinary microRNAs are a class of promising non-invasive biomarkers. Although many studies have been conducted on this topic in the last five years, there is little agreement on the data obtained. This review aims to discuss new knowledge but also focuses on technical aspects affecting urinary miRNA analysis. Current routine screening methods for the diagnosis of prostate cancer (PCa) have significantly increased early detection of the disease but often show unsatisfactory analytical parameters. A class of promising markers represents urinary microRNAs (miRNAs). In the last five years, there has been an extensive increase in the number of studies on this topic. Thus, this review aims to update knowledge and point out technical aspects affecting urinary miRNA analysis. The review of relevant literature was carried out by searching the PubMed database for the keywords: microRNA, miRNA, urine, urinary, prostate cancer, and diagnosis. Papers discussed in this review were retrieved using PubMed, and the search strategy was as follows: (urine OR urinary) WITH (microRNA OR miRNA) AND prostate cancer. The search was limited to the last 5 years, January 2017 to December 2021. Based on the defined search strategy, 31 original publications corresponding to the research topic were identified, read and reviewed to present the latest findings and to assess possible translation of urinary miRNAs into clinical practice. Reviews or older publications were read and cited if they valuably extended the context and contributed to a better understanding. Urinary miRNAs are potentially valuable markers for the diagnosis of prostate cancer. Despite promising results, there is still a need for independent validation of exploratory data, which follows a strict widely accepted methodology taking into account the shortcomings and factors influencing the analysis.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Circulating microRNAs in Cancer: A 5-Year Update with a Focus on Breast and Lung Cancers
    Siniscalco, Dario
    Galderisi, Umberto
    Peluso, Gianfranco
    Finicelli, Mauro
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (06)
  • [2] VMAT SBRT for localized prostate cancer: 5-year update on toxicity and survival
    D'Agostino, G. R.
    Di Brina, L.
    Franzese, C.
    Iftode, C.
    Mancosu, P.
    De Rose, F.
    Clerici, E.
    Reggiori, G.
    Badalamenti, M.
    Scorsetti, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S625 - S626
  • [3] Urinary microRNAs expression in prostate cancer diagnosis: a systematic review
    Paiva, R. M.
    Zauli, D. A. G.
    Neto, B. S.
    Brum, I. S.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (11): : 2061 - 2073
  • [4] Urinary microRNAs expression in prostate cancer diagnosis: a systematic review
    R. M. Paiva
    D. A. G. Zauli
    B. S. Neto
    I. S. Brum
    [J]. Clinical and Translational Oncology, 2020, 22 : 2061 - 2073
  • [5] LDR brachytherapy of "low risk" prostate cancer: Update of the 5-year experience in 118 patients
    Block, T.
    Zimmermann, F.
    Czempiel, H.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 116 - 116
  • [6] Prognostic significance of the 5-year PSA value for predicting prostate cancer recurrence following brachytherapy
    Klein, T. J.
    Stock, R. G.
    Cesaretti, J. A.
    Stone, N. N.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S176 - S177
  • [7] Anxiety and depression after prostate cancer diagnosis and treatment: 5-year follow-up
    I J Korfage
    M-L Essink-Bot
    A C J W Janssens
    F H Schröder
    H J de Koning
    [J]. British Journal of Cancer, 2006, 94 : 1093 - 1098
  • [8] Anxiety and depression after prostate cancer diagnosis and treatment:: 5-year follow-up
    Korfage, IJ
    Esskink-Bot, ML
    Janssens, ACJW
    Schröder, FH
    de Koning, HJ
    [J]. BRITISH JOURNAL OF CANCER, 2006, 94 (08) : 1093 - 1098
  • [9] Urinary microRNAs for prostate cancer diagnosis, prognosis, and treatment response: are we there yet?
    Balacescu, Ovidiu
    Petrut, Bogdan
    Tudoran, Oana
    Feflea, Dragos
    Balacescu, Loredana
    Anghel, Andrei
    Sirbu, Ioan O.
    Seclaman, Edward
    Marian, Catalin
    [J]. WILEY INTERDISCIPLINARY REVIEWS-RNA, 2017, 8 (06)
  • [10] Quetiapine: A 5-year update - Introduction
    Lieberman, JA
    Perkins, DO
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 : 3 - 4